ERBB2 and neoplasm: The methylation levels of the three representative CpG sites did not show any association with age, menopause status, ER/PR status, HER2 status, grading, tumor size, lymph node status or tumor stage in the sporadic BC patients with available clinical data (Supplementary Table S4).